
Manus Bonner
Location
Zürich
Field of Study
Economics
Expertise
Health Care
Skills
Applied Research
Big Data Analytics
Business Modeling
Data Science
Deep Learning
Enterprise Resource Planning (ERP)
Finance
Information Systems
Information system design
Management Consulting
Management Information Systems (MIS)
Mobile Health
Personalized Medicine
Portfolio Optimization
Python
Strategic Marketing
Strategic Planning
Open for
parttime
fulltime
Work Experience
Sinergia Project | University of Lausanne
2020-01 - 2020-12
Researcher
Vaud
fulltime
Development of Science of Personalized Health in Switzerland - Sinergia Project - Assess entire body of knowledge related to personalized health and precision medicine as it relates to consumer preferences and user privacy - Study transfer the concept of digital sovereignty to personalized health and precision medicine and assess the willingness-to-share - Analyze data value, data sharing and digital sovereignty in personalized health ecosystems COVID-19 Tracing Apps - Study of COVID-19 Tracing Apps as means to avoid potential second wave of COVID-19 and avoid further lockdown measures - Research was primarily geared towards understanding the consumer perspective as a benefit-risk tradeoff in the debate on uptake of COVID-19 apps - Looking specifically at user preferences as they relate to COVID-19 tracing app usage for both Swiss (SwissCOVID) and German (Warn-Corona-App) users - Empirical data confirms significant differences in benefit and risk perception between different groups of the population, classified as advocates, critics, and undecided (Trang et al.; 2020; Bonner et al.; 2020)
Bayer AG | Consumer Health
2014-03 - 2019-03
Senior Manager, Portfolio Management
Basel-Stadt
fulltime
Portfolio Management 2.0 - Established an entirely new Consumer Health portfolio management framework (PM 2.0) & incorporated into strategic planning cycle (Strategic Conference / StraCo). - Acquisitions of Dihon Pharmaceutical Group Co., Ltd. & Merck & Co's Consumer care Division and incorporation of businesses into PM2.0 framework (additional €2.1bn in revenues on top of existing business - €3.7bn turnover p.a.). - Rolled out PM2.0 globally as key strategic guardrail and embedded in both budgeting and StraCo planning cycles Strategic Tailend Management - Best-in-Bayer M&A framework designed and built for managing divestiture & discontinuation of tailend brands/non-strategic priority brands - Identified €200m+ of saleable / non-priority assets / brands of which over €120m have now been slated for divestment - System/tool designer & architect, charged with all financial and cross-functional operations
Bayer AG | Bayer HealthCare
2012-03 - 2014-03
Strategic Analyst
Basel-Stadt
fulltime
Finance lead on Portfolio Management implementation ensuring optimal resource allocation for priority markets and global brands, outlining strategic options for future growth. Strategic guardrails implemented based on portfolio designations for top 20 global markets backup up by StraCo (5-yr strategic controlling plan). StraCo system designer and co-architect. Team lead for global rollout and implementation.
Academic Experience
University of Basel -
2004.04 - 2008.09
Master of Science, MSc in Economics & Business